← Leaderboards
Miryam Yusufov
Dana-Farber Cancer Inst
$604,958
Attributed
$604,958
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $152.7K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$604,958 · 1
By mechanism
K08$604,958 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Gary G Bennett$17,084,880
- Andrea C Enzinger$2,832,837
- Shoshana M Rosenberg$2,061,263
- Alexi A Wright$5,090,186
Others in their field
Other Rising Stars on “Advanced Malignant Neoplasm”
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
- Channapatna S. Prakash · Tuskegee University$7,931,772
- Paola A Ramos · Mayo Clinic Rochester$7,298,203
- Erin Leahy · Icf, Inc., Llc$6,884,676
Research focus
Advanced Malignant NeoplasmAcceptability And FeasibilityAreaAwardAnxietyBehaviorBehavioralBehavioral ModelBehavioral OutcomeBehavioral TrialBehavior ChangeBehavior TherapyCancer CareCancer PainCancer PatientCareerCareer DevelopmentCare OutcomesCategoriesCenter For Translational Science ActivitiesClinicClinical ResearchClinical SciencesComprehensive Cancer Center
Grant awards (4)
A Novel Intervention for Avoidance-Related Opioid Misuse in Patients with Cancer$149,896
K08 · FY2025 · CA · contact PI
A Novel Intervention for Avoidance-Related Opioid Misuse in Patients with Cancer$151,077
K08 · FY2024 · CA · contact PI
A Novel Intervention for Avoidance-Related Opioid Misuse in Patients with Cancer$151,248
K08 · FY2023 · CA · contact PI
A Novel Intervention for Avoidance-Related Opioid Misuse in Patients with Cancer$152,737
K08 · FY2022 · CA · contact PI